truxal 50 mg ml injection - search results

Ireland - English - HPRA (Health Products Regulatory Authority)

dexamethasone phosphate 4 mg/ml solution for injection/infusion

as kalceks - dexamethasone sodium phosphate - solution for injection/infusion - dexamethasone

Ireland - English - HPRA (Health Products Regulatory Authority)

stemetil 12.5 mg/ml solution for injection - 1 ml ampoule

sanofi-aventis ireland limited t/a sanofi - prochlorperazine mesilate - solution for injection - 12.5 milligram(s)/millilitre - phenothiazines with piperazine structure; prochlorperazine

Israel - English - Ministry of Health

cubicin 500 mg

merck sharp & dohme (israel - 1996) company ltd, israel - daptomycin - lyophilized powder for solution for injection - daptomycin 500 mg/vial - daptomycin - cubicin is indicated for the treatment of the infections listed below. * complicated skin and skin structure infectionscomplicated skin and skin structure infections (csssi) caused by susceptible isolates of the following gram-positive bacteria: staphylococcus aureus (including methicillin-resistant isolates), streptococcus pyogenes, streptococcus agalactiae, streptococcus dysgalactiae subsp. equisimilis, and enterococcus faecalis (vancomycin-susceptible isolates only).* staphylococcus aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolatesstaphylococcus aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates.* combination therapy may be clinically indicated if the documented or presumed pathogens include gram negative or anaerobic organisms